1. Home
  2. TORO vs EMBC Comparison

TORO vs EMBC Comparison

Compare TORO & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Corp.

TORO

Toro Corp.

HOLD

Current Price

$4.97

Market Cap

173.8M

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.30

Market Cap

207.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TORO
EMBC
Founded
2022
1924
Country
Cyprus
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.8M
207.1M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
TORO
EMBC
Price
$4.97
$3.30
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
33.7K
2.5M
Earning Date
04-15-2026
05-05-2026
Dividend Yield
36.86%
6.88%
EPS Growth
N/A
20.90
EPS
N/A
0.67
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.00
Revenue Growth
N/A
N/A
52 Week Low
$2.16
$2.77
52 Week High
$8.50
$15.55

Technical Indicators

Market Signals
Indicator
TORO
EMBC
Relative Strength Index (RSI) 45.83 41.83
Support Level $4.89 $3.01
Resistance Level $5.85 $3.48
Average True Range (ATR) 0.28 0.18
MACD 0.00 0.12
Stochastic Oscillator 36.99 56.12

Price Performance

Historical Comparison
TORO
EMBC

About TORO Toro Corp.

Toro Corp is engaged in the acquisition, ownership, chartering, and operation of oceangoing tanker and LPG carrier vessels, providing seaborne transportation services for crude oil, refined petroleum products, and liquefied petroleum gas. The company operates through three segments: the Eco tanker segment, the Non-Eco tanker segment, and the LPG carrier segment. It generates the majority of its revenue from the LPG carrier segment.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: